Summary
d-Lysine, the non-physiological isomer of l-lysine, can competitively reduce protein non-enzymatic glycation in vitro. To study the effect of d-lysine in vivo, 6–8-week old Sprague-Dawley rats with streptozotocin-induced diabetes mellitus were treated from diagnosis for 45 days with two daily subcutaneous injections of d-lysine (0.5 g·ml−1·day−1). Another group of diabetic rats was only injected with equal volumes of physiological saline (0.9% NaCl). Glycated haemoglobin was measured by ion exchange chromatography, and glycated serum and lens proteins by boronate affinity gel chromatography. Serum and urinary creatinine concentrations were evaluated by the alkaline-picrate reaction. Urinary lysine concentrations at mid- and end-study were evaluated by cation exchange chromatography. Blood glucose concentrations, serum creatinine levels and creatinine clearances, measured at the end of the study, were similar in both diabetic groups (> 22.0 mmol/l, ≤ 106 μmol/l and ≈ 0.02 ml/s, respectively). Urinary lysine concentration in d-lysine-treated diabetic animals was more than 50-fold higher than in placebo-treated diabetic rats. In d-lysine-treated vs placebo-treated diabetic animals, a statistically significant reduction was found in the levels of glycated haemoglobin (stable HbA1; mean ± SD=3.00±0.74% vs 4.02±0.46%, p<0.05; labile HbA1=3.92±0.89% vs 5.84±0.61%, p<0.005), glycated serum proteins (1.40±0.47% vs 2.52±1.15%, p<0.05) and glycated lens proteins (4.90±0.96% vs 5.98±0.65 %,p<0.05). Thus, d-lysine (i) is not nephrotoxic and (ii) causes a significant reduction of the early glycation products at the protein level. Therefore, the d-amino acid could be useful in attempting to control damaging phenomena associated with or due to an enhanced protein non-enzymatic glycation.
Article PDF
Similar content being viewed by others
References
Monnier VM (1989) Toward a Maillard reaction theory of aging. In: Baines JW, Monnier VM (eds) The Maillard reaction in aging, diabetes and nutrition. Alan R. Liss, New York, pp 1–22
Monnier VM, Cerami A (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211: 491–493
Cerami A (1985) Hypothesis: glucose as mediator of aging. J Am Ger Soc 33: 626–634
Monnier VM (1990) Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 45: B105-B111
Brownlee M, Vlassara H, Cerami A (1984) Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 101: 527–537
Sensi M, Pricci F, Andreani D, Di Mario U (1991) Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res 16: 1–9
Rendell M, Njerenberg J, Brannan C et al. (1986) Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo. J Lab Clin Med 108: 286–293
Sensi M, Bruno MR, Pozzilli P (1987) In vitro inhibition of nonenzymic glycosylation induced by aspirin. Med Sci Res 15: 99–100
Štolba P, Hátle K, Krñáková A, Streda M, Stárka L (1987) Effects of ascorbic acid on nonenzymatic glycation of serum proteins in vitro and in vivo. Diabetologia 30: A585 (Abstract)
Davie SJ, Gould BJ, Yudkin JS (1992) Effect of vitamin C on glycosylation of proteins. Diabetes 41: 167–173
Bruno MR, Sensi M, Cioccia GP et al. (1988) Inhibition of protein non-enzymatic glycation induced by Bendazac. Diabetes Res 9: 11–14
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629–1632
Nicholls K, Mandel TE (1989) Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60: 486–491
Kumari K, Umar S, Bansal V, Sahib MJ (1991) Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes 40: 1079–1084
Oxlund H, Andreassen TT (1992) Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia 35: 19–25
Means GE, Chang MK (1982) Nonenzynaatic glycosylation of proteins: structure and function changes. Diabetes 31 [Suppl 3]: 1–4
Neuberger A, Sanger F (1944) The metabolism of lysine. Biochem J 38: 119–125
Doty J, Eaton AG (1937) The metabolism of lysine: studies on the heat production and blood and urine constituents after administration of d-lysine monohydrochloride to the dog. Am J Phys 119: 296–297
Sensi M, Pricci F, De Rossi MG, Morano S, Di Mario U (1989) d-lysine effectively decreases the non-enzymatic glycation of proteins in vitro. Clin Chem 35: 384–387
Sensi M, Pricci F, Bellarosa D, Pugliese G, Morano S, Di Mario U (1990) Reduced formation of advanced glycation end products induced by d-lysine: preliminary in vitro observations. In: Belfiore F, Molinatti GM, Reaven GM (eds) Tissue-specific metabolic alterations in diabetes. Frontiers in Diabetes, vol 10. Karger, Basel Munich Paris London New York Tokyo Sydney, pp 158–160
Perrett D (1985) Liquid chromatographic separation of amino acids and their derivatives. In: Barrett GC (ed) The chemistry and biochemistry of amino acids. Chapman & Hall, London, pp 426–461
Mallia AK, Hermanson GT, Krohn RI, Fujimoto EK, Smith PK (1981) Preparation and use of boronic acid affinity support for separation and quantitation of glycosylated hemoglobins. Anal Letters 14:649–661
Zager AR, Venkatachalam AM (1983) Potentiation of ischemic renal injury by amino acid infusion. Kidney Int 24: 620–625
Racusen LC, Finn WF, Whelton A, Solez K (1985) Mechanisms of lysine-induced acute renal failure in rats. Kidney Int 27: 517–522
Kaltenback JP, Ganote CE, Carone FA (1979) Renal tubular necrosis induced by compounds structurally related to d-serine. Exp Mol Path 30:209–211
Meister A (1965) Biochemistry of the amino acids. Vol. 1. Academic Press, New York London
Nagata Y, Akino T, Ohno K et al. (1987) Free d-amino acids in human plasma in relation to senescence and renal disease. Clin Sci 73:105–108
Schepartz B (1973) Regulation of amino acid metabolism in mammals. Amino acid transport. W.B. Saunders, Philadelphia London Toronto
Ortwerth BJ, Olesen PR (1988) Ascorbic acid-induced crosslinking of lens proteins: evidence supporting a Maillard reaction. Biochim Biophys Acta 956:10–22
Menzel EJ, Reihsner R (1991) Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine. Diabetologia 34:12–16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sensi, M., De Rossi, M.G., Celi, F.S. et al. d-Lysine reduces the non-enzymatic glycation of proteins in experimental diabetes mellitus in rats. Diabetologia 36, 797–801 (1993). https://doi.org/10.1007/BF00400352
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400352